Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort

Abstract Background Blood-based Alzheimer’s disease (AD) biomarkers have been increasingly employed for diagnostic, prognostic, and therapeutic monitoring purposes, due to accuracy in distinguishing AD pathophysiologic process. Compared to other p-tau isoforms, plasma p-tau217 exhibits stronger asso...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Neetesh Pandey, Zikun Yang, Basilio Cieza, Dolly Reyes-Dumeyer, Min Suk Kang, Rosa Montesinos, Marcio Soto-Añari, Nilton Custodio, Lawrence S. Honig, Giuseppe Tosto
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-01-01
coleção:	Alzheimer’s Research & Therapy
Assuntos:	Alzheimer’s disease Plasma biomarker P-tau217 Plasma APOE
Acesso em linha:	https://doi.org/10.1186/s13195-024-01655-w
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!